Health News Update: August 4, 2014

By ACSH Staff — Aug 04, 2014
Related content:
What I'm Reading (Aug. 17)
More of the same: EWG and Sen. Lautenberg promote precautionary principle
Are hepatitis C drugs too expensive?
New therapies with a very new price tag What to do?
Some rare common sense in our healthcare system? Treating hepatitis C, and getting it right
Catch the latest news on concerns regarding Gilead's $84,000 hepatitis C treatment drug Sovaldi, the declining sales of traditional cigarettes, and why prior authorization could be hurting the health care system

Catch the latest news on concerns regarding Gilead's $84,000 hepatitis C treatment drug Sovaldi, the declining sales of traditional cigarettes, and why prior authorization could be hurting the health care system

Tags:
Category
Harm Reduction

ACSH Staff

Recent articles by this author:
Fukushima's Tritiated Water
Investigation: Scientology-Linked Lawyers Spread Lies About Vaccines and GMOs, Attack Scientists
ACSH, Paul Thacker, and His 'Thacker of Trolls'
Why a Vaccine Can Provide Better Immunity than an Actual Infection
Perchlorate in Drinking Water
All articles by this author
ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles

ACSH Podcasts

Latest from Henry

Latest from Josh

Latest from Chuck